Back to results
CompletedPhase 4

Mechanisms of Weight Loss With SGLT2 Inhibition

NCT02360774

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

View on ClinicalTrials.gov
Mechanisms of Weight Loss With SGLT2 Inhibition — TrialFind